Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. TAYS

Source: Site record.

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

We provide highly specialized healthcare and services for people with developmental disabilities, while creating opportunities for health sciences research and education.Our activities are based on ethical principles: high-quality care, respect for people, appreciation of expertise, and responsibility. Our work is embodied in the motto “For Life.”

Business Status

Source: Google. OPEN

Business Category

Source: Google. University hospital

Business Subcategory

Source: Google. University hospital
Source: Trial-derived.
46Total Trials
Source: Trial-derived.
16Recruiting Trials
Source: Trial-derived.
24Active Trials
Source: Trial-derived.
17Completed Trials
Source: Trial-derived.
55Unique Conditions
Source: Trial-derived.
78Unique Sponsors

Conditions

Source: Trial-derived. Ovarian Cancer (3)Source: Trial-derived. Chronic Kidney Disease (2)Source: Trial-derived. Fluid Overload (2)Source: Trial-derived. Leukemia, Acute Lymphoblastic (2)Source: Trial-derived. Proteinuria (2)Source: Trial-derived. Renal Cell Carcinoma (2)Source: Trial-derived. Type 1 Diabetes (2)Source: Trial-derived. Urothelial Carcinoma (2)

Sponsors

Source: Trial-derived. Tampere University Hospital (15)Source: Trial-derived. Merck Sharp & Dohme LLC (11)Source: Trial-derived. Bayer (4)Source: Trial-derived. Oulu University Hospital (4)Source: Trial-derived. Turku University Hospital (4)Source: Trial-derived. Eisai Inc. (3)Source: Trial-derived. European Network of Gynaecological Oncological Trial Groups (ENGOT) (3)Source: Trial-derived. GOG Foundation (3)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. Echocardiography
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. PET-CT
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Circulating tumour DNA testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Radiopharmaceutical handling and administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intensive care (ICU)
Source: AI-inferred. Peripheral angiography and endovascular intervention
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. CT angiography
Source: AI-inferred. Cystoscopy
Source: AI-inferred. Diabetes-related islet autoantibody testing
Source: AI-inferred. Electronic patient diary (ePRO) system
Source: AI-inferred. Electronic patient diary (ePRO/eDiary) system
Source: AI-inferred. Interferon-gamma release assay (QuantiFERON-TB)
Source: AI-inferred. Mail-based specimen collection
Source: AI-inferred. Radiopharmaceutical biodistribution and dosimetry analysis